MedTrace Logo

Acupuncture for Chemo-Induced Peripheral Neuropathy in Multiple Myeloma Patients

NCT04770402 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2025-01-27

Study results available
· View outcomes & findings →

Summary

This randomized, controlled trial is designed to evaluate the effect of acupuncture on Chemotherapy-Induced Peripheral Neuropathy (CIPN), other symptoms, and potential opioid and concomitant medication sparing effects in comparison to standard of care management in Multiple Myeloma subjects.

Conditions

  • Chemotherapy-induced Peripheral Neuropathy

Interventions

OTHER

Acupuncture

12 acupuncture sessions over 10 weeks

OTHER

Standard of Care CIPN management

Investigator directed standard of care management of CIPN

Sponsors & Collaborators

  • Atrium Health Levine Cancer Institute

    collaborator OTHER

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Shamille Hariharan, MD · Wake Forest University Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-15
Primary Completion
2023-04-06
Completion
2023-04-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04770402 on ClinicalTrials.gov